Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v12-EN | Version v7-FR | |
|---|---|---|
| Language | English | French |
| Date Updated | 2021-10-15 | 2021-10-06 |
| Drug Identification Number | 02401029 | 02401029 |
| Brand name | CEFAZOLIN FOR INJECTION, USP | CEFAZOLIN FOR INJECTION, USP |
| Common or Proper name | Cefazolin for Injection, USP 100 g SmartPak® | Cefazolin for Injection, USP 100 g SmartPak® |
| Company Name | FRESENIUS KABI CANADA LTD | FRESENIUS KABI CANADA LTD |
| Ingredients | CEFAZOLIN | CEFAZOLIN |
| Strength(s) | 100G | 100G |
| Dosage form(s) | POWDER FOR SOLUTION | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS | INTRAVENOUS INTRAVENOUS |
| Packaging size | 100 g | 100 g |
| ATC code | J01DB | J01DB |
| ATC description | OTHER BETA-LACTAM ANTIBACTERIALS | OTHER BETA-LACTAM ANTIBACTERIALS |
| Reason for shortage | Delay in shipping of the drug. | Delay in shipping of the drug. |
| Anticipated start date | 2021-09-24 | 2021-09-24 |
| Actual start date | ||
| Estimated end date | 2021-10-14 | 2021-10-12 |
| Actual end date | 2021-10-14 | |
| Shortage status | Resolved | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | Fresenius Kabi Canada regrets to advise that due to a shipping delay, we will be encountering a supply interruption on our Cefazolin for Injection, USP 100 g SmartPak® effective September 24, 2021 until October 12, 2021. | |
| Health Canada comments |